Antigen-presenting cells and tolerance induction

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 1, 2002, Pages 2-8

  Von Bubnoff, D ^a   De La Salle, H ^b   Wessendorf J ^a   Koch, S ^a   Hanau, D ^b   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Lymphoid dendritic cells; Myeloid dendritic cells; T cell tolerance; Tryptophan degradation

Indexed keywords

ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL SUBPOPULATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; AUTOANTIGENS; HUMANS; IMMUNE TOLERANCE; MICE; T-LYMPHOCYTES;

EID: 0036163024     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.01150.x     Document Type: Review

References (66)

1. + T cells resulting in a failure to lyse tumor cells
2. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
3. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
4. T cell tolerance by clonal elimination in the thymus
5. + thymocytes
6. Does T-cell tolerance require a dedicated antigen-presenting cell?
7. 'Promiscuous' expression of tissue antigens in the thymus, a key to T-cell tolerance and autoimmunity?
8. Tolerance and autoimmunity
9. An unexpected version of horror autotoxicus: Anaphylactic shock to a self-peptide
10. + T-cell tolerance by cross-presentation of self antigens
11. CD8 (+) but not CD8 (-) dendritic cells cross-prime cytotoxic T cells in vivo
12. Cross-presentation, dendritic cells, tolerance and immunity
13. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells
14. 2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12
15. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor
16. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
17. In vivo effects of a bacterial superantigen on macaque TCR repertoires
18. Peripheral tolerance in T cell receptor-transgenic mice: Evidence for T cell anergy
19. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells
20. Inhibition of T cell proliferation by macrophage tryptophan catabolism
21. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation
22. Prevention of allogeneic fetal rejection by tryptophan catabolism
23. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy
24. CTLA-4 up-regulation plays a role in tolerance mediated by CD45
25. Engagement of the PD-I immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
26. PD-L2 is a second ligand for PD-I and inhibits T cell activation
27. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
28. Molecular mimicry and autoimmunity
29. Chemokines: Immunology's high impact factors
30. Immunological tolerance to inhaled antigen
31. Oral tolerance in myelin basic protein T-cell receptor transgenic mice, suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells
32. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
33. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature
34. Immunobiology of dendritic cells
35. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
36. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL) -3 and CD40-ligand
37. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
38. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
39. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
40. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
41. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
42. Reciprocal control of T helper cell and dendritic cell differentiation
43. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
44. Dendritic cells and the control of immunity
45. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor
46. Macrophage subpopulations and macrophage-derived cytokines in sputum of atopic and nonatopic asthmatic subjects and atopic and normal control subjects
47. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance
48. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo
49. The induction of tolerance by dendritic cells that have captured apoptotic cells
50. B cells turn off virgin but not memory T cells
51. The role of macrophages in antigen presentation and T cell tolerance
52. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
53. Antigen presentation by parenchymal cells: A route to peripheral tolerance?
54. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
55. Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization
56. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: A model to study marginal organ donors
57. A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state
58. IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo
59. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
60. Induction of tolerance by IL-10-treated dendritic cells
61. High level IL-12 production by murine dendritic cells, upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
62. Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7
63. CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells
64. Indoleamine 2,3-dioxygenase: Antioxidant enzyme in the human eye
65. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?
66. Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system